Authors:
Horwitz, EM
Winter, K
Hanks, GE
Lawton, CA
Russell, AH
Machtay, M
Citation: Em. Horwitz et al., Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy, INT J RAD O, 49(4), 2001, pp. 947-956
Citation: Ah. Russell et al., Anal sphincter conservation for patients with adenocarcinoma of the distalrectum: Long-term results of Radiation Therapy Oncology Group Protocol 89-02, INT J RAD O, 46(2), 2000, pp. 313-322
Authors:
Cox, JD
Scott, CB
Byhardt, RW
Emami, B
Russell, AH
Fu, KK
Parliament, MB
Komaki, R
Gaspar, LEW
Citation: Jd. Cox et al., Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): Analysis of radiation therapy oncology group (RTOG) trials, INT J RAD O, 43(3), 1999, pp. 505-509
Authors:
Cooper, JS
Guo, MD
Herskovic, A
Macdonald, JS
Martenson, JA
Al-Sarraf, M
Byhardt, R
Russell, AH
Beitler, JJ
Spencer, S
Asbell, SO
Graham, MV
Leichman, LL
Citation: Js. Cooper et al., Chemoradiotherapy of locally advanced esophageal cancer - Long-term follow-up of a prospective randomized trial (RTOG 85-01), J AM MED A, 281(17), 1999, pp. 1623-1627
Authors:
Bonin, SR
Pajak, TF
Russell, AH
Coia, LR
Paris, KJ
Flam, MS
Sauter, ER
Citation: Sr. Bonin et al., Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal - A report of randomized trial RTOG87-04, CANCER, 85(6), 1999, pp. 1226-1233